- Report
- February 2026
- 282 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 389 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 486 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 197 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 192 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 387 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 387 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 390 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 149 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 169 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 177 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 413 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 288 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 235 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 183 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 478 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 289 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 384 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 250 Pages
Global
From €5101EUR$5,850USD£4,445GBP
- Report
- February 2026
- 422 Pages
Global
From €5101EUR$5,850USD£4,445GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more